🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to learn about the immune response after a RSVp...
Status
Recruiting
Location
Tsuchiura Beryl Clinic
Start Date
2026-05-11
Trial ID
NCT07543380
Treatments Being Tested
Substudy A: The study aims to learn about the safety and effects of two new...
Status
Completed
Location
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Start Date
2023-03-09
Trial ID
NCT05788237
The purpose of this phase 3 multicenter, double-blinded, placebo-controlled...
Status
Recruiting
Location
King George Hospital
Start Date
2026-06-22
Trial ID
NCT07653100
This Pfizer-sponsored real-world retrospective non-interventional study wil...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2025-08-11
Trial ID
NCT07122661
Treatments Being Tested
This clinical trial is studying the newly licensed RSV vaccines in adults o...
Status
Completed
Location
University of Rochester Medical Center
Start Date
2023-11-07
Trial ID
NCT06077149
Treatments Being Tested
This study evaluates whether the RSV vaccine Abrysvo can produce an antibod...
Status
Not Yet Recruiting
Location
Cooper University Hospital
Start Date
2026-01-01
Trial ID
NCT07296120
Treatments Being Tested
This study will be conducted in collaboration with a research network of in...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2024-08-26
Trial ID
NCT06647654
Treatments Being Tested
Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3...
Status
Active Not Recruiting
Location
St. Vincent's Birmingham (Pharmacy)
Start Date
2021-08-31
Trial ID
NCT05035212
Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory...
Status
Completed
Location
Emory University School of Medicine
Start Date
2024-09-19
Trial ID
NCT06551506
This purpose of this phase 3 multicenter, parallel-group, open-label study ...
Status
Completed
Location
Central Research Associates
Start Date
2025-04-04
Trial ID
NCT06890416
Treatments Being Tested